FAP-Others| 毕得医药

搜索购物车会员中心

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid: BD012631812374782-03-197%; ￥1563.05mg

(S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)(methyl)amino)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid: BD014831022374782-04-298%; ￥1009.01mg

(S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid: BD011974722374782-02-098%; ￥2138.010mg

(S)-N-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide: BD5607231448440-52-597%; ￥1263.050mg

(S)-4-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-8-yl)amino)-4-oxobutanoic acid: BD014416532639365-69-698%; ￥696.01mg

NH2-UAMC1110 TFA: BD0220595898%; ￥

FAP-IN-2 TFA: BD0230632798%; ￥

(S)-2,2'-(7-(2-(4-(3-((4-((2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid: BD015138202374782-76-8; ￥

2,2',2''-(10-(2-((2-((((12S,32S,5R,13R,16S,19S,22S)-19-(3-Amino-3-oxopropyl)-16-benzyl-13-carboxy-5-hexanamido-22-((R)-1-hydroxyethyl)-2,4,15,18,21,24-hexaoxo-7,11-dithia-14,17,20,23-tetraaza-1(1,2),3(2,1)-dipyrrolidina-9(1,3)-benzenacyclotetracosaphane-95-yl)methyl)thio)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid: BD015401472581741-18-495%; ￥

((R)-1-(Isonicotinoyl-D-alanyl)pyrrolidin-2-yl)boronic acid: BD017278841432499-49-498%; ￥

FAPI-34: BD015076232374782-07-598%; ￥

2-(Aminomethyl)-N-((S)-1-((S)-2-cyano-4,4-difluoropyrrolidin-1-yl)-1-oxopropan-2-yl)isonicotinamide: BD020347252230625-76-895%; ￥

Fluorogen binding modulator-1: BD01646136510716-65-198%; ￥

(S)-N-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-(3-(piperazin-1-yl)propoxy)quinoline-4-carboxamide: BD013103102471983-20-597%; ￥

FAP-IN-1: BD023161772956858-96-998%; ￥

3BP-3940: BD025550862803421-14-795%; ￥

Suc-Gly-Pro-AMC: BD0119677980049-85-098%; ￥19383.0100mg

(S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid: BD012940912370952-98-898%; ￥

Ac-Gly-BoroPro: BD00805566886992-99-098%; ￥7476.0100mg

1